from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2297/-

LFCtreatmentdescriptionclass of inhibitor

0.439

Amikacinug/mL Amikacintranslation

-0.804

Cap5-10ug/mL Capreomycintranslation

-0.025

Rox10-50 ug/mL Roxithromycintranslation

0.124

SM2-5 ug/mL Streptomycintranslation

-0.411

Tet5-10 ug/mL Tetracyclinetranslation

0.180

Rif0.2-5ug/mL Rifampicintranscription

0.310

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.376

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.175

CPZ10-50 ug/mL Chlorpromazinerespiration

1.412

Clofazimine10-13 ug/mL Clofaziminerespiration

1.135

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.080

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.349

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.158

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.093

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.588

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.611

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

-0.481

NaN30.2-2 mM Sodium aziderespiration

-0.369

Nigericin50 uM Nigericinrespiration

0.059

TRC10-150 ug/mL Triclosanrespiration

1.574

TRZ10-25 ug/mL Thioridazinerespiration

-1.384

Valinomycin0.5-10 uM Valinomycinrespiration

0.838

ZnSO42 mM ZnSO4respiration

-1.264

menadione6-10 ug/mL Menadionerespiration

0.118

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.223

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.150

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.310

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.432

NRP_1Non-replicating persistence stage 1dosRassociated

0.349

Amp0.2mg/mL AmpicillincellWall

-0.192

Cephalexin20-100 ug/mL CephalexincellWall

-0.147

Cerulenin0.32-5 ug/mL CerulenincellWall

0.704

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.240

EMB10-20 ug/mL EthambutolcellWall

-0.208

Eta12-40 ug/mL EthionamidecellWall

-0.642

INH0.2-0.4 ug/mL IsoniazidcellWall

0.367

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.104

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.331

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.076

BZA0.12 mg/mL BenzamidearomaticAmides

-0.560

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.112

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.775

H2O24 mM hydrogen peroxideDNAdamaging

-0.297

Levo10 ug/mL LevofloxacinDNAdamaging

0.117

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.033

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.175

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.299

Antimycin12.5-50 ug/mL Antimycin A?

-0.142

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.242

PA_110-50 ug/mL Antitubercular compound PA-1?

0.167

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.480

PA8240.2-2 ug/mL PA-824?

-1.227

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.118

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.377

Verapamil50 uM Verapamil?

-0.321

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.667

methoxatin10-20 ug/mL Methoxatin?